Related Experiment Video

Updated: Jul 5, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

[Treatment perspectives for critical limb ischemia: gene and cell therapy]

Elisa Pasqualoni1, Emmanuel Messas, Jean-Noël Fiessinger

  • 1Service de médecine vasculaire - HTA, Hôpital européen Georges Pompidou, F75908 Paris Cedex 15, France.

Presse Medicale (Paris, France : 1983)
|May 3, 2008
PubMed

Insights

Critical limb ischemia (CLI) poses high amputation and death risks. Gene and cell therapies show promise for stimulating blood vessel growth in non-surgical CLI patients, but large trials are needed to confirm benefits.

Area of Science:

  • Vascular biology
  • Regenerative medicine
  • Clinical trial design

Context:

  • Critical limb ischemia (CLI) presents a significant clinical challenge with high rates of amputation and mortality.
  • Current therapeutic options for patients with CLI unsuitable for surgical revascularization are limited and have not demonstrated efficacy in reducing amputation rates.
  • Gene and cell therapies are emerging as potential strategies to address CLI by promoting angiogenesis.

Purpose:

  • To evaluate the feasibility and safety of gene and cell therapies for stimulating angiogenesis in patients with critical limb ischemia.
  • To assess the potential of these novel therapeutic approaches in a clinical setting.

Summary:

  • Phase I and II clinical trials have investigated gene and cell therapies aimed at promoting angiogenesis in CLI patients.
  • These innovative treatments have demonstrated feasibility and safety in early-stage investigations.
  • No current medical options effectively reduce the 6-month amputation rate in surgically unrevascularizable CLI patients.

Impact:

  • Gene and cell therapies represent a promising avenue for treating critical limb ischemia.
  • Further research, particularly large randomized clinical trials, is essential to establish the long-term benefits and safety of these therapies.
  • Successful development could lead to improved outcomes and reduced amputation rates for CLI patients.

More Related Videos

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...